Auswahl der wissenschaftlichen Literatur zum Thema „Ulcerative colitise“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Ulcerative colitise" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Ulcerative colitise"
Costa, Gabrielle Azevêdo, Giovanna Souza Carvalho, Lenzzy Coelho Pereira, Stephanie Gesteira Vilas Boas Sena Costa und Cristina Aires Brasil. „Epidemiological Profile of Patients with Crohn's Disease and Ulcerative Colitis in the Last 6 Years“. Journal of Health Sciences 24, Nr. 1 (22.03.2022): 63–66. http://dx.doi.org/10.17921/2447-8938.2022v24n1p63-66.
Der volle Inhalt der QuelleTobin, Jacinta M., Bidisa Sinha, Pramila Ramani, Abdul R. H. Saleh und M. Stephen Murphy. „Upper Gastrointestinal Mucosal Disease in Pediatric Crohn Disease and Ulcerative Colitis: A Blinded, Controlled Study“. Journal of Pediatric Gastroenterology and Nutrition 32, Nr. 4 (April 2001): 443–48. http://dx.doi.org/10.1002/j.1536-4801.2001.tb07295.x.
Der volle Inhalt der QuelleGarey, Kevin W., Daniel S. Streetman und Michael C. Rainish. „Azathioprine Hypersensitivity Reaction in a Patient with Ulcerative Colitis“. Annals of Pharmacotherapy 32, Nr. 4 (April 1998): 425–28. http://dx.doi.org/10.1345/aph.17395.
Der volle Inhalt der QuelleSilvia Pop, Corina, Roxana Maria Nemes und George Pariza. „Surgical Approaches in Fulminant Ulcerative Colitis“. Global Journal For Research Analysis 3, Nr. 5 (15.06.2012): 115–17. http://dx.doi.org/10.15373/22778160/may2014/43.
Der volle Inhalt der QuelleTomasik, Mikołaj, Paweł Warzyszak, Róża Małek, Maria Milczek, Wojciech Żołyniak, Izabela Hawranik, Szymon Niski, Ziemowit Żaba, Aleksandra Lisowska und Mateusz Skrzypek. „Ulcerative colitis – recent and potential methods of treatment - review“. Journal of Education, Health and Sport 13, Nr. 3 (17.01.2023): 65–73. http://dx.doi.org/10.12775/jehs.2023.13.03.009.
Der volle Inhalt der QuelleArellano, Nelson Darío, und Larissa Inés Páez. „Colectomy for severe ulcerative colitis“. Anales de la Facultad de Ciencias Médicas (Asunción) 54, Nr. 2 (30.08.2021): 151–56. http://dx.doi.org/10.18004/anales/2021.054.02.151.
Der volle Inhalt der QuelleSoni, Dr Aakanksha. „Evaluation of the Factors Associated with Post-Operative Outcome in Patients of Ulcerative Colitis Undergoing Ileal Pouchanal Anastomosis with Comparison of Functional Outcome between Stapler and Hand-Sewn Anastomosis“. Journal of Medical Science and clinical Research 12, Nr. 01 (31.01.2024): 11–19. http://dx.doi.org/10.18535/jmscr/v12i01.03.
Der volle Inhalt der QuelleJaeger, Karine Nava, Maria Eduarda Mintzfels Branco, Ileana Simone de Oliveira Moura, Lorenzo Gabriel de Azevedo Viera, Jhoni Michael de Oliveira Cardoso, Caroline Bezerra Trajano dos Santos, Carlos Galvão Branco Araújo et al. „Segurança do Vedolizumabe no tratamento da Retocolite Ulcerativa: Uma revisão de literatura.“ Brazilian Journal of Implantology and Health Sciences 6, Nr. 1 (26.01.2024): 1918–26. http://dx.doi.org/10.36557/2674-8169.2024v6n1p1918-1926.
Der volle Inhalt der QuelleProujansky, Roy, Paul T. Fawcett, Kathleen M. Gibney, William R. Treem und Jeffrey S. Hyams. „Examination of Anti‐Neutrophil Cytoplasmic Antibodies in Childhood Inflammatory Bowel Disease“. Journal of Pediatric Gastroenterology and Nutrition 17, Nr. 2 (August 1993): 193–97. http://dx.doi.org/10.1002/j.1536-4801.1993.tb10946.x.
Der volle Inhalt der QuelleLakatos, László, und Péter László Lakatos. „Medical therapy of inflammatory bowel diseases: Ulcerative colitis“. Orvosi Hetilap 148, Nr. 25 (01.06.2007): 1163–70. http://dx.doi.org/10.1556/oh.2007.28063.
Der volle Inhalt der QuelleDissertationen zum Thema "Ulcerative colitise"
Rivière, Pauline Mayalen. „FMIcroorganisms as Triggers in Acute severe ulcerative Colitis and their influence on medical therapy efficacy : a multi-omics approach, the ITAC project“. Electronic Thesis or Diss., Bordeaux, 2023. http://www.theses.fr/2023BORD0474.
Der volle Inhalt der QuelleAcute severe ulcerative colitis is a specific ulcerative colitis (UC) flare characterised by systemic inflammation on top of bloody diarrhoea, leading to a 20% risk of colectomy and 1% mortality risk. Little is known about acute severe ulcerative colitis pathophysiology. Microorganisms have been proposed as triggers for acute severe ulcerative colitis because of the similarity, most notably systemic inflammation, between this phenotype and infectious colitis. Moreover, gut microbiota are key players for protection against pathogens and in UC inflammation. We hypothesised that a dysfunctional gut microbiome, characterised by a lack of diversity and the loss of anti-inflammatory bacterial species, would allow the proliferation of a pathobiont in the colonic lumen eliciting a systemic inflammatory response in hosts with permissive gut mucosal immunity leading to an acute severe ulcerative colitis flare. The general objective of my study was to identify the microbiome component(s) and the host factors leading to acute severe ulcerative colitis. We had three specific aims: (i) to compare the gut microbiota of patients with acute severe ulcerative colitis compared to patients with a non-severe ulcerative colitis flare using 16S rRNA gene sequencing of stool samples and rectal biopsies. Patients with acute severeulcerative colitis displayed significant alterations in their gut microbiota, characterised by reduced alpha-diversity, an increased presence of Proteobacteria, particularly members of the Escherichia/Shigella genus, and a reduction in the abundance of Lachnospiraceae and Ruminococcaceae family members; (ii) to identify the cellular subtypes and pathways involved in gut mucosal inflammation in acute severe ulcerative colitis patients compared to non-severe ulcerative colitis patients by single-cell RNA-Seq of rectal biopsies. In severe cases, plasmablasts exhibited a distinct transcriptomic profile with increased IgG production, 2and a specific T cell population expressing IL26 was expanded compared to non-severe cases. Innate immune cells displayed a pro-inflammatory profile. Both T cells and innate immune cells indicated a pro-Th17 mucosal environment; (iii) to determine the host pathways mediating the systemic inflammatory outburst using whole blood RNA-Seq in acute severe ulcerative colitis patients compared to non-severe ulcerative colitis patients. We found no clear distinction between severe and non-severe cases and did not identify any pathways enriched with differentially expressed genes. This observation suggests that in acute severe ulcerative colitis, the systemic inflammation is less likely to be orchestrated by cytokines originating from circulating cells but rather from inflammatory cells located in the colonic mucosa. This multi-omics study contributes valuable insights into the pivotal cellular and bacterial components involved in the pathogenesis of acute severe ulcerative colitis. These findings have the potential to guide future clinical research, directing efforts toward microbiome modulation, targeted interventions on plasmablasts, or nuanced inhibition of the Th17/IL-23 axis
Maldaun, Daisy 1944. „Analise qualitativa dos aspectos emocionais e vivenciais de pacientes idosos portadores de retocolite ulcerativa inespecifica em atendimento ambulatorial“. [s.n.], 2006. http://repositorio.unicamp.br/jspui/handle/REPOSIP/252522.
Der volle Inhalt der QuelleDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Educação
Made available in DSpace on 2018-08-06T15:30:21Z (GMT). No. of bitstreams: 1 Maldaun_Daisy_M.pdf: 580822 bytes, checksum: f5f1e583f2cc833273662dd98f503183 (MD5) Previous issue date: 2006
Resumo: Desde a Antiguidade, sabe-se, através dos registros da História, que sentimentos e emoções apresentam uma ressonância no corpo. No decorrer dos séculos, o avanço da medicina permitiu o conhecimento da existência de mecanismos através dos quais as emoções podem dar origem ao processo do adoecer. O objetivo deste estudo foi compreender os aspectos emocionais como a ansiedade, o medo e a raiva de pacientes com idade entre 51 e 74 anos portadores de Retocolite Ulcerativa Inespecífica (RCUI) - doença inflamatória intestinal de etiologia desconhecida, bem como viabilizar os resultados desta pesquisa a familiares e profissionais da saúde, numa tentativa de mostrar sua relevância no surgimento e evolução da doença. Como método de pesquisa, optou-se pelo Clínico-Qualitativo. Foram estudados oito (08) casos de pacientes portadores de RCUI, de ambos os sexos, com idades entre 51 e 74 anos. Como procedimento de investigação, foram realizadas entrevistas semidirigidas de questões abertas, levando em consideração a verbalização dos doentes em relação às mudanças ocorridas em suas vidas após o surgimento da doença. Quanto aos resultados, o referencial teórico utilizado para a sua interpretação foi baseado nos conceitos usuais da Psicologia Médica e da Medicina Psicossomática. e da Psicologia Compreensiva Explicativa e Fenomenológica de JASPERS,K. Considerou-se, após a avaliação dos aspectos emocionais desses pacientes através de seus depoimentos, que sua influência é relevante no desencadear e na evolução da RCUI. A psicoterapia, como um instrumento de ajuda e suporte ao tratamento clínico, deve colocar-se a serviço deste Ser doente e em prol da possibilidade de elaboração de uma nova forma de ele vivenciar a doença e seus conflitos, sejam quais forem os recursos de que ele dispõe para manifestá-los
Abstract: Ever since the early Ages, it is common knowledge that feelings and emotions resonate in the body. Throughout the centuries, the advance of medicine has brought to light the knowledge of existing mechanisms through which emotions can give rise to the process of getting sick. The objective of this study was to understand the emotional aspects, such as anxiety, fear and rage of patients aged between 51 and 74 with Unspecified Ulcerative Colitis, an inflammatory intestinal disease of unknown etiology. We also aim to make the results of the present study available to patients¿ family members and health professionals as a means to raise their awareness of the relevance of emotional aspects to the rise and evolution of the illness. The Method chosen to carry out the study was the Qualitative-Clinical Method; eight (08) patients of both sexes were studied. The investigative procedure consisted of semi-direct interviews of open questions; taking into consideration the patients¿ accounts on the changes occurred in their lives before and after the illness manifested itself. The theoretical reference point used for the interpretation of the results was based on the usual concepts of Medical Psychology and Psychosomatic Medicine and of the Comprehensible Explanatory Psychology and Phenomenology of JASPERS, K. Following the evaluation of the emotional aspects these patients mentioned in their testimonials, we concluded that they have great influence on the manifestation of the illness, and that psychotherapy, as an instrument of support for the clinical treatment, should be applied to offer them a new means of understanding the causes of their suffering in the search for a way to deal with the disease and the conflicts it brings along, regardless of which resources they may have available to do so
Mestrado
Gerontologia
Mestre em Gerontologia
Luchini, Ana Carolina. „Avaliação dos efeitos da cumarina e da 4-hidroxi-cumarima e de diferentes associações com a sulfassalazina no modelo de colite induzida por ácido trinitrobenzenosulfônico (TNBS) em ratos /“. Botucatu, 2009. http://hdl.handle.net/11449/102429.
Der volle Inhalt der QuelleBanca: Célia Akiko Hiruma
Banca: Claudia Helena Pellizzon
Banca: Alessandra Gambero
Banca: Marcelo Aparecido da Silva
Resumo: As cumarinas representam uma importante classe de compostos fenólicos com inúmeras propriedades farmacológicas que incluem inibição da peroxidação lipídica, da geração de ânion superóxido dependente de neutrófilos, da citotoxicidade induzida por hidroperóxido de ácido linoleíco, da atividade de lipooxigenases e ciclooxigenases, além de agirem como agentes imunossupressores e antiinflamatórios. Todas estas propriedades são essenciais para que um produto seja potencialmente ativo para o tratamento das doenças inflamatórias intestinais (DII). A sulfassalazina (primeira opção terapêutica no tratamento das DII) possui vários efeitos colaterais, especialmente quando usada em altas doses ou em períodos longos de tratamento. O objetivo do presente trabalho foi avaliar se cumarina e 4-hidroxi-cumarina possuem efeitos preventivos e/ou curativos no modelo de colite induzida por ácido trinitrobenzenosulfônico (TNBS) em ratos e também se as associações de cumarina ou 4-hidroxi-cumarina com doses menores de sulfassalazina produzem efeitos antiinflamatórios com menor incidência de efeitos colaterais decorrentes da administração da sulfassalazina. Além disso, foram feitos estudos complementares para verificar se tais cumarinas modulam a produção de citocinas próinflamatórias em cultivos celulares in vitro e ex vivo. Este estudo testou a atividade antiinflamatória dos compostos-testes cumarina (2,5 a 50mg/Kg) e 4-hidroxicumarina (5 a 50mg/Kg) e das associações de cumarina com a sulfassalazina (C5+S5; C5+S15 e C5+S25) ou da 4-hidroxi-cumarina com a sulfassalazina (4-OHC25+S5, 4-OHC25+S15 e 4-OHC25+S25) em duas condições experimentais distintas: quando a mucosa colônica está intacta (efeito preventivo); quando a mucosa colônica está afetada por um processo inflamatório intestinal (efeito curativo) assim como preventivo da recidiva do processo inflamatório ... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: Coumarins comprise an important class of phenolic compounds with many pharmacological properties that includes inhibition of membrane lipid peroxidation, inhibition on neutrophil-dependent superoxide anion generation, inhibition on the linoleic acid hydroperoxide-induced cytotoxicity, and inhibition on cyclooxygenase and lipoxygenase activities, which could result in antiinflammatory and immunosuppressant effect. Those are some desired features for a candidate compound in the treatment of inflammatory bowel diseases (IBD). On the other hand, the IBD are life persisting diseases with unpredictable episodic reactivations and difficult treatment in severe cases. Sulfasalazine, the first choice drug in the treatment of mild to moderately active IBD cases, presents serious side effects when used in high doses or in long-term treatment. Thus, the aim of this study was to evaluate the effects of coumarin and 4-hydroxy-coumarin in rat experimental intestinal inflammation. Additionally, we evaluated the possibility of coumarins association to sulfasalazine in rat intestinal inflammatory conditions. For this purpose, the antiinflammatory activity of test compounds, coumarin (2.5 to 50mg/kg) and 4-hydroxy-coumarin (5 to 50mg/kg) and associations of coumarin with sulfasalazine (C5 plus S5, C5 plus S15, C5 plus S25) or 4-hydroxy-coumarin with sulfasalazine (4-OHC25 plus S5, 4-OHC25 plus S15 and 4-OHC25 plus S25) were tested in the model of trinitrobenzenesulphonic acid (TNBS) induced rat colitis in two different experimental conditions: when the colonic mucosa is intact (preventive effect), and when a previous inflammatory damage is caused to the colonic mucosa (curative effect), additionally to a reactivation of the inflammatory process (relapse prevention). The colonic damage was evaluated macroscopically, histologically and biochemically. For cell cultures evaluation of cytokine ... (Complete abstract click electronic access below)
Doutor
Hartmann, Renata Minuzzo. „O efeito antioxidante da Boswellia serrata no modelo experimental de colite induzida por ácido acético“. reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2012. http://hdl.handle.net/10183/70400.
Der volle Inhalt der QuelleIntroduction: Ulcerative rectocolitis is an inflammatory disease that involves only the colon and rectum, being characterized by leukocyte infiltrate and superficial ulcers in the intestinal mucosa. The production and release of reactive oxygen and nitrogen species appears to be crucial in determining the pathophysiology of the disease, since both result in oxidative damage. Therefore, the search for treatment options with antioxidant properties is important currently and has been tested in experimental colitis. Objective: This study aimed to evaluate the effects of dry extract of Boswellia serrata plant in an experimental model of colitis induced by acetic acid on tissue injury, anal sphincter pressure, oxidative stress, on the activity of antioxidant enzymes superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione (GSH), concentration of nitric oxide metabolites and expression of inducible nitric oxide synthase enzyme (iNOS) by immunohistochemistry. Methods: We used 25 male Wistar rats with an average weight of 350g, divided into 5 groups: control (CO), Control + Boswellia serrata (CO+B); Colitis (CL); Colitis + Boswellia serrata (CL+B) and Boswellia serrata + colitis (B+CL). The animals were submitted to intracolonic administration by enema with acetic acid solution diluted to 4% in a volume of 4 ml. The treatment with aqueous plant extract was performed orally at a dose of 34.2 mg/kg diluted in 4 ml of saline. The administration occurred once daily for 48 hours before and after the induction of colitis. We performed the measurement of anal sphincter pressure animals. Histological analyzes of bowel the after were made staining with hematoxylin-eosin and immunohistochemistry, performed with iNOS antibody. The homogenized intestine was used for evaluation of lipid peroxidation (LPO) through thiobarbituric acid reactive substances (TBARS), assessment of nitric oxide metabolites by the technique of total nitrites and nitrates and evaluation of the antioxidant enzymes SOD, GPx and GSH. Results: The analysis of anal sphincter pressure of the animals in groups CL+B and B+CL showed a significant increase when compared to the CL group. LPO and nitric oxide metabolites levels demonstrated significant decrease in groups CL+B and B+CL when compared to CL. SOD activity showed an increase in CL group and a significant decrease in groups CL+B and B+CL, remainig to the average of the CO group. The GPx and GSH showed a significant increase in groups CL+B and B+CL group when compared to CL group. Conclusion: We suggest that the administration of Boswellia serrata plant extract may be a possibility of antioxidant therapy in ulcerative colitis.
Almeida, Maristela Gomes de. „"Estudo da microbiota intestinal em doentes com retocolite ulcerativa antes e após retocolectomia com anastomose de bolsa ileal ao canal anal"“. Universidade de São Paulo, 2004. http://www.teses.usp.br/teses/disponiveis/5/5154/tde-19102005-160653/.
Der volle Inhalt der QuelleThe aim of this study is to describe the intestinal microbiota of patients with severe ulcerative colitis, under clinical treatment, before and after proctocolectomy and ileal pouch-anal anastomosis. Intestinal flora of distal ileum and rectum before surgery was compared with the flora found in ileal pouch after two and eight months after ileostomy closure and with the flora of distal ileum and rectum of controls. Veillonella sp was the most frequent microorganism found in all groups. There were no significant differences between the intestinal microbiota found in controls and in patients with ulcerative colitis
Thomas, Gareth Andrew Osbert. „Nicotine therapy for ulcerative colitis“. Thesis, Queen Mary, University of London, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309526.
Der volle Inhalt der QuellePullan, Rupert Derek. „Colonic mucus and ulcerative colitis“. Thesis, University of Oxford, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.358954.
Der volle Inhalt der QuelleBurke, Denis Anthony. „Ulcerative colitis and Escherichia coli“. Thesis, University of Newcastle Upon Tyne, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309075.
Der volle Inhalt der QuelleFinnie, Ian A. „Mucosal metabolism and ulcerative colitis“. Thesis, University of Aberdeen, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.342167.
Der volle Inhalt der QuelleHearing, Stephen David. „Steroid resistance in ulcerative colitis“. Thesis, University of Bristol, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.324259.
Der volle Inhalt der QuelleBücher zum Thema "Ulcerative colitise"
Poggioli, Gilberto, Hrsg. Ulcerative Colitis. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3.
Der volle Inhalt der QuelleR, Gibson P., Hrsg. Ulcerative colitis. London: Baillière Tindall, 1997.
Den vollen Inhalt der Quelle findenNational Digestive Diseases Information Clearinghouse (U.S.). Ulcerative colitis. Bethesda, Md: U.S. Dept. of Health and Human Services, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Digestive Diseases Information Clearinghouse, 2006.
Den vollen Inhalt der Quelle findenA, Ó'Moráin Colm, Hrsg. Ulcerative colitis. Boca Raton: CRC Press, 1991.
Den vollen Inhalt der Quelle findenLichtenstein, Gary R. Ulcerative Colitis. Boca Raton: CRC Press, 2024. http://dx.doi.org/10.1201/9781003526827.
Der volle Inhalt der Quelle1939-, Jagelman David, Hrsg. Mucosal ulcerative colitis. Mount Kisco, N.Y: Futura Pub. Co., 1986.
Den vollen Inhalt der Quelle findenSaibil, Fredric G. Crohn's disease & ulcerative colitis. Toronto: Key Porter Books, 1996.
Den vollen Inhalt der Quelle findenSaibil, Fredric G. Crohn's disease & ulcerative colitis. 2. Aufl. Toronto: Key Porter Books, 2003.
Den vollen Inhalt der Quelle findenSaibil, Fredric G. Crohn's disease & ulcerative colitis. Willowdale, Ont: Firefly Books, 1997.
Den vollen Inhalt der Quelle findenP, Kelly Michael. Colitis. London: Taylor & Francis Group Plc, 2004.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Ulcerative colitise"
Poggioli, Gilberto, Marco Salice, Nicola Renzi und Massimo Campieri. „History of Ulcerative Colitis“. In Ulcerative Colitis, 1–16. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_1.
Der volle Inhalt der QuellePoggioli, Gilberto, und Matteo Rottoli. „Surgical Treatment of Ulcerative Colitis: Laparoscopy and New Minimally Invasive Techniques“. In Ulcerative Colitis, 139–53. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_10.
Der volle Inhalt der QuellePoggioli, Gilberto, Lorenzo Gentilini, Maurizio Coscia und Federica Ugolini. „Results and Quality of Life after Surgical Treatment of Ulcerative Colitis“. In Ulcerative Colitis, 155–71. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_11.
Der volle Inhalt der QuellePoggioli, Gilberto, Lorenzo Gentilini, Maurizio Coscia und Federica Ugolini. „Long-term Complications after Surgical Treatment of Ulcerative Colitis“. In Ulcerative Colitis, 173–94. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_12.
Der volle Inhalt der QuellePoggioli, Gilberto, Laura Vittori und Silvio Laureti. „Management and Treatment of Fistulas after Surgical Treatment of Ulcerative Colitis“. In Ulcerative Colitis, 195–210. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_13.
Der volle Inhalt der QuellePoggioli, Gilberto, und Nicola Renzi. „Presentation and Natural Course of Ulcerative Colitis“. In Ulcerative Colitis, 17–28. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_2.
Der volle Inhalt der QuelleSerra, Carla, Chiara Praticò und Alberta Cappelli. „Diagnosis of Ulcerative Colitis: the Role of Imaging Techniques“. In Ulcerative Colitis, 29–44. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_3.
Der volle Inhalt der QuellePoggioli, Gilberto, Massimo P. Di Simone und Laura Vittori. „Diagnosis of Ulcerative Colitis: the Role of Endoscopy“. In Ulcerative Colitis, 45–60. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_4.
Der volle Inhalt der QuelleD’Errico, Antonietta, und Deborah Malvi. „Diagnosis of Ulcerative Colitis: Morphology and Histopathological Characteristics“. In Ulcerative Colitis, 61–92. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_5.
Der volle Inhalt der QuelleRizzello, Fernando, Marco Salice, Carlo Calabrese, Marta Mazza, Andrea Calafiore, Lucia Calandrini, Hana Privitera Hrustemovic, Massimo Campieri und Paolo Gionchetti. „Medical Treatment of Ulcerative Colitis: Does Traditional Therapy Still Have a Role?“ In Ulcerative Colitis, 93–104. Milano: Springer Milan, 2019. http://dx.doi.org/10.1007/978-88-470-3977-3_6.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Ulcerative colitise"
Wiziack, Matheus da Silva, VITOR ANDRADE, PEDRO RAFAEL MACEDO, ANA CAROLINE RIBEIRO LIMA BORGES und LARISSA SOARES DE ANDRADE. „FATORES IMUNOLÓGICOS DO EFEITO PROTETIVO DO TABACO NA COLITE ULCERATIVA“. In II Congresso Brasileiro de Imunologia On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/ii-conbrai/5968.
Der volle Inhalt der QuelleJodeleit, H., O. Al-amodi, J. Caesar, G. Schütze, L. Holdt, M. Siebeck, R. Gropp und F. Beigel. „Targeting Ulcerative Colitis with Ritonavir“. In 46. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1648609.
Der volle Inhalt der QuelleIrandost, M., B. Varda und A. I. Saeed. „Pulmonary Manifestations of Ulcerative Colitis“. In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1384.
Der volle Inhalt der QuelleAleskerov, F. „Atypical Presentation of Ulcerative Colitis“. In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3577.
Der volle Inhalt der QuelleSantos, Daniel Rocha, und Cintya Lopes Caravella Ribeiro. „ASSOCIAÇÃO DE CORTICÓIDES E BIOLÓGICOS NO TRATAMENTO DA RETOCOLITE ULCERATIVA – UMA REVISÃO SISTEMÁTICA“. In I Congresso Brasileiro de Saúde Pública On-line: Uma abordagem Multiprofissional. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/2871.
Der volle Inhalt der QuelleGada, K., P. S. Masuta und D. N. Manta. „Atypical Pulmonary Manifestations of Ulcerative Colitis“. In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1387.
Der volle Inhalt der QuelleBramantya, Rendy Revandana, Iswan Abbas Nusi, Poernomo Boedi Setiawan, Herry Purbayu, Titong Sugihartono, Ummi Maimunah, Ulfa Kholili et al. „Diagnosis and Management of Ulcerative Colitis“. In Surabaya International Physiology Seminar. SCITEPRESS - Science and Technology Publications, 2017. http://dx.doi.org/10.5220/0007339804050412.
Der volle Inhalt der QuelleSahu, N., A. K. Rahman, C. Simone, M. DiRico, E. B. Ernst und N. Fitzpatrick. „The Airway of Refractory Ulcerative Colitis“. In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1440.
Der volle Inhalt der QuelleKacmaz, Rukiye Nur, und Bulent Yilmaz. „Detection of Ulcerative Colitis From Colonoscopy Images“. In 2018 Medical Technologies National Congress (TIPTEKNO). IEEE, 2018. http://dx.doi.org/10.1109/tiptekno.2018.8596841.
Der volle Inhalt der QuelleHammami, A., A. Hassine, F. Zinelabidine, Ameur W. Ben, W. Dahmani, N. Elleuch, A. Braham et al. „Assessment of the Severity of Endoscopic Lesions in Ulcerative Colitis: Endoscopist’s Evaluation Versus Ulcerative Colitis Endoscopic Index Score“. In ESGE Days 2021. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1724754.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Ulcerative colitise"
Tang, Li-li, Yue-dong Liu, Hong-wu Tao, Wen-zhe Feng, Yu-ping Shu und Fan-yan Meng. The efficacy and safety of ulcerative colitis treatment based on the theory of the " lung–gut axis ": a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, März 2023. http://dx.doi.org/10.37766/inplasy2023.3.0014.
Der volle Inhalt der QuelleChengyulin, Wang, Nie Yingjun und Wu Qiaofeng. Acupucture for Ulcerative Colitis: A systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2020. http://dx.doi.org/10.37766/inplasy2020.11.0075.
Der volle Inhalt der QuelleYang, Dan, Lijiao Yan, Qiulu Mai, Hailing Guo und Yufang Hao. Navel therapy for Ulcerative Colitis in adults: a systematic review and meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Dezember 2020. http://dx.doi.org/10.37766/inplasy2020.12.0146.
Der volle Inhalt der QuelleHuang, Chih-Wen, Hsu-Heng Yen und Yang-Yuan Chen. Network Meta-Analysis of Rescue Treatments for Steroid-Refractory Acute Severe Ulcerative Colitis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, März 2024. http://dx.doi.org/10.37766/inplasy2024.3.0113.
Der volle Inhalt der QuelleGuo, Xinyi, Changxing Liu und Yahui Huang. Efficacy and safety of vitamin D adjuvant therapy for ulcerative colitis: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Mai 2022. http://dx.doi.org/10.37766/inplasy2022.5.0044.
Der volle Inhalt der QuelleZhang, Yitao, Tongxin Liu, Chunxiao Yan, Ling Li, Jiaqi Zhang und Liangrong Zhou. The Acupuncture-related Therapies for Ulcerative Colitis: A protocol for systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, März 2022. http://dx.doi.org/10.37766/inplasy2022.3.0102.
Der volle Inhalt der Quellezhao, tian, shi qin und lu fu. Efficacy and safety of Janus kinase inhibitors for Ulcerative colitis:A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Dezember 2021. http://dx.doi.org/10.37766/inplasy2021.12.0096.
Der volle Inhalt der QuelleLiu, Chenyu, Xin Liu, Haitao Shi, Fenrong Chen, Linlang Sun, Xin Gao und Yan Wang. The correlation between serum 25-hydroxyvitamin D level and ulcerative colitis: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2023. http://dx.doi.org/10.37766/inplasy2023.8.0081.
Der volle Inhalt der QuelleXiong, PeiYu, Yuhang Ren, Chun Zhong, Peixu Zhang, Xu Chen, Xinglong Chen und Bo Jia. Treatment of Ulcerative colitis with Chinese herbal medicine enema: a protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Oktober 2020. http://dx.doi.org/10.37766/inplasy2020.10.0091.
Der volle Inhalt der QuelleTaxonera, Carlos, und David Olivares. Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis: A systematic review and meta-analysis. Peeref, Juni 2023. http://dx.doi.org/10.54985/peeref.2306p5797828.
Der volle Inhalt der Quelle